These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14624709)

  • 21. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
    Reboul FL
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.
    Wang HQ; Ren Y; Qian ZZ; Fu K; Zhang HL; Li W; Hou Y; Zhou SY; Hao XS; Xie CH
    Thorac Cancer; 2012 Feb; 3(1):72-78. PubMed ID: 28920255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal duration of chemotherapy in advanced non-small cell lung cancer.
    Lustberg MB; Edelman MJ
    Curr Treat Options Oncol; 2007 Feb; 8(1):38-46. PubMed ID: 17634834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer.
    Evans TL; Lynch TJ
    Oncologist; 2001; 6(5):407-14. PubMed ID: 11675518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinations of three chemotherapeutic agents and two chemotherapeutic agents plus a targeted biologic agent in the treatment of advanced non small-cell lung cancer.
    Bunn PA; Kelly K
    Clin Lung Cancer; 2000 Dec; 2 Suppl 1():S23-8. PubMed ID: 14725732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential of antiangiogenic therapy in non-small cell lung cancer.
    Giaccone G
    Clin Cancer Res; 2007 Apr; 13(7):1961-70. PubMed ID: 17404076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecularly-targeted therapies for non-small cell lung cancer.
    Ramalingam S; Belani CP
    Expert Opin Pharmacother; 2005 Dec; 6(15):2667-79. PubMed ID: 16316305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current standards of care in small-cell and non-small-cell lung cancer.
    Schiller JH
    Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy.
    Herbst RS; Lynch TJ; Sandler AB
    Clin Lung Cancer; 2009 Jan; 10(1):20-7. PubMed ID: 19289368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing chemotherapy and targeted agent combinations in NSCLC.
    Lynch T; Kim E
    Lung Cancer; 2005 Dec; 50S2():S25-S32. PubMed ID: 16551519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-intensive therapy in lung cancer.
    Elias A
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S64-9. PubMed ID: 9272137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-line treatment for advanced non-small-cell lung cancer.
    Laskin JJ; Sandler AB
    Oncology (Williston Park); 2005 Nov; 19(13):1671-6; discussion 1678-80. PubMed ID: 16425521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in chemotherapy of non-small cell lung cancer.
    Molina JR; Adjei AA; Jett JR
    Chest; 2006 Oct; 130(4):1211-9. PubMed ID: 17035458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments.
    Gridelli C; Maione P; Rossi A; De Marinis F
    Oncologist; 2007 Oct; 12(10):1183-93. PubMed ID: 17962612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
    Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
    Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New agents in the treatment of small-cell lung cancer: focus on gemcitabine.
    Chiappori AA; Rocha-Lima CM
    Clin Lung Cancer; 2003 Jan; 4 Suppl 2():S56-63. PubMed ID: 14720338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
    Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
    Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists.
    Silvestri GA; Rivera MP
    Chest; 2005 Dec; 128(6):3975-84. PubMed ID: 16354869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-surgical therapy for patients with advanced non-small cell lung cancer.
    Liao M
    Respirology; 1998 Sep; 3(3):151-7. PubMed ID: 9767613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.